Vital Therapies Inc (VTL)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Vital Therapies Inc (VTL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013511
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute liver failure by processing toxins and synthesizing proteins. Vital Therapies’s ELAD System contains immortal human liver-derived cells or VTL C3A cells that performs biochemical functions characteristic of human hepatocytes in in-vitro assays. Vital Therapies also provides programs for severe acute alcoholic hepatitis and alcohol induced liver decompensation, surgery-induced liver failure, fulminant liver failure, and chronic liver failure. It also conducts clinical trials. Vital Therapies is headquartered in San Diego, California, the US.

Vital Therapies Inc (VTL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Vital Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Vital Therapies Inc, Medical Devices Deals, 2011 to YTD 2017 9
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Vital Therapies Raises US$32 Million In Venture Financing 11
Vital Therapies Raises US$12 Million In Venture Financing 12
Vital Therapies Increases Size Of Financing To US$100 Million 13
Vital Therapies Secures USD4.35 Million in Venture Funding 15
Equity Offering 16
Vital Therapies Raises USD40.3 Million in Public Offering of Shares 16
Vital Therapies Raises USD34.5 Million in Public Offering of Shares 18
Vital Therapies Completes Partial Exercise of Underwriter’s Over Allotment Option of Public Offering of Shares for USD36 Million 20
Vital Therapies Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$62.1 Million 22
Vital Therapies Inc – Key Competitors 24
Vital Therapies Inc – Key Employees 25
Vital Therapies Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Oct 25, 2017: Vital Therapies Announces Third Quarter 2017 Financial Results 27
Aug 03, 2017: Vital Therapies Announces Second Quarter 2017 Financial Results 29
May 09, 2017: Vital Therapies Announces First Quarter 2017 Financial Results 30
Mar 07, 2017: Vital Therapies Announces Fourth Quarter and Full Year 2016 Financial Results 31
Nov 03, 2016: Vital Therapies Announces Third Quarter Financial Results 32
Aug 02, 2016: Vital Therapies Announces Second Quarter Financial Results 33
May 09, 2016: Vital Therapies Announces First Quarter Financial Results 34
Mar 08, 2016: Vital Therapies Announces Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update 35
Corporate Communications 37
Sep 06, 2017: Vital Therapies Appoints Former Receptos President and CEO Faheem Hasnain as Chairman of the Board of Directors 37
Aug 15, 2016: Vital Therapies Announces Appointment of Former Receptos President and CEO Faheem Hasnain to Its Board of Directors 38
Clinical Trials 39
Jun 05, 2017: Vital Therapies Announces Characteristics of Early Subjects in VTL-308 Pivotal Study of ELAD System in Severe Alcoholic Hepatitis 39
May 23, 2016: Vital Therapies Enrolls First Subject in VTL-308 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Vital Therapies Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Vital Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Vital Therapies Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Vital Therapies Inc, Medical Devices Deals, 2011 to YTD 2017 9
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Vital Therapies Raises US$32 Million In Venture Financing 11
Vital Therapies Raises US$12 Million In Venture Financing 12
Vital Therapies Increases Size Of Financing To US$100 Million 13
Vital Therapies Secures USD4.35 Million in Venture Funding 15
Vital Therapies Raises USD40.3 Million in Public Offering of Shares 16
Vital Therapies Raises USD34.5 Million in Public Offering of Shares 18
Vital Therapies Completes Partial Exercise of Underwriter's Over Allotment Option of Public Offering of Shares for USD36 Million 20
Vital Therapies Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$62.1 Million 22
Vital Therapies Inc, Key Competitors 24
Vital Therapies Inc, Key Employees 25
Vital Therapies Inc, Subsidiaries 26

★海外企業調査レポート[Vital Therapies Inc (VTL)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Karolinska University Hospital-製薬・医療分野:企業M&A・提携分析
    Summary Karolinska University Hospital (KUH), a subsidiary of Karolinska Institutet is a healthcare service provider that offers patient care, research and education programs. The hospital offers cross border medical care by referring patients or by tele medicine and health care at a distance. It of …
  • Vedanta Resources Plc
    Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Navios Maritime Partners L.P.:企業のM&A・事業提携・投資動向
    Navios Maritime Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navios Maritime Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Encision Inc (ECIA):医療機器:M&Aディール及び事業提携情報
    Summary Encision Inc (Encision) is a medical device company that manufactures and markets surgical instruments. The company provides laparoscopic monopolar surgical instruments. Its product portfolio includes AEM burn protection systems, AEM instrumentation, cord adapter, inhibit adapter extension, …
  • Pioneer Natural Resources Co Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Pioneer Natural Resources Co Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Pioneer Natural Resources Co (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, …
  • National Dentex Corp:企業の戦略的SWOT分析
    National Dentex Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Martin Resource Management Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Martin Resource Management Corp (MRMC) is an oil and gas service provider that markets and distributes fuel oil, asphalt, sulfuric acid, diesel fuel and naphthenic lubricants. The company provides transportation, marketing, terminalling and logistics management services for hydrocarbon produ …
  • Inotek Pharmaceuticals Corp (RCKT):製薬・医療:M&Aディール及び事業提携情報
    Summary Inotek Pharmaceuticals Corp (IPC) is a clinical-stage biopharmaceutical company that focus on the discovery and development of novel therapeutics for the treatment of glaucoma and serious diseases of the eye. The company’s trabodenoson is a selective adenosine mimetic that stimulates a speci …
  • Zynerba Pharmaceuticals Inc (ZYNE)-製薬・医療分野:企業M&A・提携分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz, Inc., focuses on the development of next-generation synthetic cannabinoid therapeutics. The company’s pipeline product candidates include ZYN002 and ZYN001. Zynerba’s ZYN002 is a synthetic CBD, a non-psychoactive canna …
  • Continental Resources, Inc.:企業の戦略・SWOT・財務分析
    Continental Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Continental Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Green Plains Inc.:企業のM&A・事業提携・投資動向
    Green Plains Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Green Plains Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Discovery Communications, Inc.
    Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • U.S. Geothermal Inc. (HTM):企業の財務・戦略的SWOT分析
    U.S. Geothermal Inc. (HTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Taewoong Medical Co Ltd:企業の製品パイプライン分析2018
    Summary Taewoong Medical Co Ltd (Taewoong Medical) is a medical device company that develops and manufactures stents and other medical devices. The company offers products such as self-expandable metal stent, endoscopic RFA, endoscopic accessory, ureteral stent, airway stent, colonic stent, surgical …
  • Alnylam Pharmaceuticals Inc (ALNY):企業の財務・戦略的SWOT分析
    Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Shanghai Kehua Bio-engineering Co Ltd (002022):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, ch …
  • Veridian Corporation:企業の戦略的SWOT分析
    Veridian Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Lisega SE:企業の戦略的SWOT分析
    Lisega SE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Symantec Corporation:企業の戦略・SWOT・財務分析
    Symantec Corporation - Strategy, SWOT and Corporate Finance Report Summary Symantec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Infinite Group Inc (IMCI):企業の財務・戦略的SWOT分析
    Summary Infinite Group Inc (IGI) is a technology company that offers IT service and support solutions virtualization and cybersecurity. The company offers Nodeware, an automated network vulnerability management system that assesses vulnerabilities in a computer network using scanning technology. Its …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆